Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2008 | 12-2007 | |
| Sales | 0 | 0 | 0 | 18,502,000 | 12,690,000 |
| Cost of Goods | N/A | N/A | N/A | 7,307,000 | 4,405,000 |
| Gross Profit | N/A | N/A | N/A | 11,195,000 | 8,285,000 |
| Operating Expenses | 41,449 | 27,064 | 14,230 | 10,352,000 | 12,148,000 |
| Operating Income | -41,449 | -27,064 | -14,230 | 843,000 | -3,863,000 |
| Other Income | 1,580 | -2,100 | 911 | 1,206,000 | 2,648,000 |
| Pre-tax Income | -39,869 | -29,164 | -13,319 | 2,049,000 | -1,215,000 |
| Income Tax | 0 | N/A | N/A | 146,000 | 258,000 |
| Net Income Continuous | -39,869 | -29,164 | -13,319 | 1,903,000 | -1,473,000 |
| Net Income | $-39,869 | $-29,164 | $-13,319 | $1,903,000 | $-1,473,000 |
| EPS Basic Total Ops | -17.98 | -16.31 | -7.66 | 1.08 | -1.04 |
| EPS Basic Continuous Ops | -17.98 | -16.31 | -7.66 | 1.08 | -1.04 |
| EPS Diluted Total Ops | -17.98 | -16.31 | -7.66 | 1.07 | -1.04 |
| EPS Diluted Continuous Ops | -17.98 | -16.31 | -7.66 | 1.07 | -1.04 |
| EPS Diluted Before Non-Recurring Items | -17.98 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-40,837 | $-26,793 | $-14,108 | $3,018,000 | $-3,002,000 |